The Experts below are selected from a list of 30 Experts worldwide ranked by ideXlab platform

Soo Young Kim - One of the best experts on this subject based on the ideXlab platform.

  • A Comparison of the Efficacy and Safety of Non-Steroidal Anti-Inflammatory Drugs versus Acetaminophen in Symptom Relief for the Common Cold: A Meta-Analysis of Randomized Controlled Trial Studies
    Korean journal of family medicine, 2013
    Co-Authors: Il-kwon Choi, Hyun-keun Lee, In-hong Hwang, Soo Young Kim
    Abstract:

    Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are widely used for Common Cold Symptom relief. The objective of this study was to evaluate and compare the efficacy and safety of acetaminophen and NSAIDs in Common Cold Symptom relief using meta-analysis of randomized controlled trial. We searched MEDLINE (PubMed), Cochrane, EMBASE, CINAHL, KMbase, KoreaMed, National Assembly Library, and Riss4u for studies released through June 2012. Two authors independently extracted the data. To assess the risk of bias, the Cochrane Collaborations risk of bias tool was used. The Review Manager ver. 5.1 (RevMan) was used for statistics. We identified 5 studies. The relative benefit for participants with pain relief was 1.00 (95% confidence interval [CI], 0.96 to 1.05) and I(2) = 0%. The existence of the heterogeneity between studies was not important in this study, thus subgroup analysis was not implemented. The relative benefit for participants with rhinorrhea was 1.02 (95% CI, 0.77 to 1.35) and I(2) = 0%, which also indicates the existence of heterogeneity was not important. The relative risk of adverse events was 1.14 (95% CI, 0.93 to 1.40), I(2) = 0%. There was no apparent asymmetry in the funnel plot. There was no difference between NSAIDs and acetaminophen in Common Cold Symptom relief.

  • a comparison of the efficacy and safety of non steroidal anti inflammatory drugs versus acetaminophen in Symptom relief for the Common Cold a meta analysis of randomized controlled trial studies
    Korean Journal of Family Medicine, 2013
    Co-Authors: Il-kwon Choi, Hyun-keun Lee, In-hong Hwang, Soo Young Kim
    Abstract:

    Background: Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are widely used for Common Cold Symptom relief. The objective of this study was to evaluate and compare the efficacy and safety of acetaminophen and NSAIDs in Common Cold Symptom relief using meta-analysis of randomized controlled trial. Methods: We searched MEDLINE (PubMed), Cochrane, EMBASE, CINAHL, KMbase, KoreaMed, National Assembly Library, and Riss4u for studies released through June 2012. Two authors independently extracted the data. To assess the risk of bias, the Cochrane Collaborations risk of bias tool was used. The Review Manager ver. 5.1 (RevMan) was used for statistics. Results: We identified 5 studies. The relative benefit for participants with pain relief was 1.00 (95% confidence interval [CI], 0.96 to 1.05) and I 2 = 0%. The existence of the heterogeneity between studies was not important in this study, thus subgroup analysis was not implemented. The relative benefit for participants with rhinorrhea was 1.02 (95% CI, 0.77 to 1.35) and I 2 = 0%, which also indicates the existence of heterogeneity was not important. The relative risk of adverse events was 1.14 (95% CI, 0.93 to 1.40), I 2 = 0%. There was no apparent asymmetry in the funnel plot. Conclusion: There was no difference between NSAIDs and acetaminophen in Common Cold Symptom relief.

Il-kwon Choi - One of the best experts on this subject based on the ideXlab platform.

  • A Comparison of the Efficacy and Safety of Non-Steroidal Anti-Inflammatory Drugs versus Acetaminophen in Symptom Relief for the Common Cold: A Meta-Analysis of Randomized Controlled Trial Studies
    Korean journal of family medicine, 2013
    Co-Authors: Il-kwon Choi, Hyun-keun Lee, In-hong Hwang, Soo Young Kim
    Abstract:

    Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are widely used for Common Cold Symptom relief. The objective of this study was to evaluate and compare the efficacy and safety of acetaminophen and NSAIDs in Common Cold Symptom relief using meta-analysis of randomized controlled trial. We searched MEDLINE (PubMed), Cochrane, EMBASE, CINAHL, KMbase, KoreaMed, National Assembly Library, and Riss4u for studies released through June 2012. Two authors independently extracted the data. To assess the risk of bias, the Cochrane Collaborations risk of bias tool was used. The Review Manager ver. 5.1 (RevMan) was used for statistics. We identified 5 studies. The relative benefit for participants with pain relief was 1.00 (95% confidence interval [CI], 0.96 to 1.05) and I(2) = 0%. The existence of the heterogeneity between studies was not important in this study, thus subgroup analysis was not implemented. The relative benefit for participants with rhinorrhea was 1.02 (95% CI, 0.77 to 1.35) and I(2) = 0%, which also indicates the existence of heterogeneity was not important. The relative risk of adverse events was 1.14 (95% CI, 0.93 to 1.40), I(2) = 0%. There was no apparent asymmetry in the funnel plot. There was no difference between NSAIDs and acetaminophen in Common Cold Symptom relief.

  • a comparison of the efficacy and safety of non steroidal anti inflammatory drugs versus acetaminophen in Symptom relief for the Common Cold a meta analysis of randomized controlled trial studies
    Korean Journal of Family Medicine, 2013
    Co-Authors: Il-kwon Choi, Hyun-keun Lee, In-hong Hwang, Soo Young Kim
    Abstract:

    Background: Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are widely used for Common Cold Symptom relief. The objective of this study was to evaluate and compare the efficacy and safety of acetaminophen and NSAIDs in Common Cold Symptom relief using meta-analysis of randomized controlled trial. Methods: We searched MEDLINE (PubMed), Cochrane, EMBASE, CINAHL, KMbase, KoreaMed, National Assembly Library, and Riss4u for studies released through June 2012. Two authors independently extracted the data. To assess the risk of bias, the Cochrane Collaborations risk of bias tool was used. The Review Manager ver. 5.1 (RevMan) was used for statistics. Results: We identified 5 studies. The relative benefit for participants with pain relief was 1.00 (95% confidence interval [CI], 0.96 to 1.05) and I 2 = 0%. The existence of the heterogeneity between studies was not important in this study, thus subgroup analysis was not implemented. The relative benefit for participants with rhinorrhea was 1.02 (95% CI, 0.77 to 1.35) and I 2 = 0%, which also indicates the existence of heterogeneity was not important. The relative risk of adverse events was 1.14 (95% CI, 0.93 to 1.40), I 2 = 0%. There was no apparent asymmetry in the funnel plot. Conclusion: There was no difference between NSAIDs and acetaminophen in Common Cold Symptom relief.

In-hong Hwang - One of the best experts on this subject based on the ideXlab platform.

  • A Comparison of the Efficacy and Safety of Non-Steroidal Anti-Inflammatory Drugs versus Acetaminophen in Symptom Relief for the Common Cold: A Meta-Analysis of Randomized Controlled Trial Studies
    Korean journal of family medicine, 2013
    Co-Authors: Il-kwon Choi, Hyun-keun Lee, In-hong Hwang, Soo Young Kim
    Abstract:

    Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are widely used for Common Cold Symptom relief. The objective of this study was to evaluate and compare the efficacy and safety of acetaminophen and NSAIDs in Common Cold Symptom relief using meta-analysis of randomized controlled trial. We searched MEDLINE (PubMed), Cochrane, EMBASE, CINAHL, KMbase, KoreaMed, National Assembly Library, and Riss4u for studies released through June 2012. Two authors independently extracted the data. To assess the risk of bias, the Cochrane Collaborations risk of bias tool was used. The Review Manager ver. 5.1 (RevMan) was used for statistics. We identified 5 studies. The relative benefit for participants with pain relief was 1.00 (95% confidence interval [CI], 0.96 to 1.05) and I(2) = 0%. The existence of the heterogeneity between studies was not important in this study, thus subgroup analysis was not implemented. The relative benefit for participants with rhinorrhea was 1.02 (95% CI, 0.77 to 1.35) and I(2) = 0%, which also indicates the existence of heterogeneity was not important. The relative risk of adverse events was 1.14 (95% CI, 0.93 to 1.40), I(2) = 0%. There was no apparent asymmetry in the funnel plot. There was no difference between NSAIDs and acetaminophen in Common Cold Symptom relief.

  • a comparison of the efficacy and safety of non steroidal anti inflammatory drugs versus acetaminophen in Symptom relief for the Common Cold a meta analysis of randomized controlled trial studies
    Korean Journal of Family Medicine, 2013
    Co-Authors: Il-kwon Choi, Hyun-keun Lee, In-hong Hwang, Soo Young Kim
    Abstract:

    Background: Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are widely used for Common Cold Symptom relief. The objective of this study was to evaluate and compare the efficacy and safety of acetaminophen and NSAIDs in Common Cold Symptom relief using meta-analysis of randomized controlled trial. Methods: We searched MEDLINE (PubMed), Cochrane, EMBASE, CINAHL, KMbase, KoreaMed, National Assembly Library, and Riss4u for studies released through June 2012. Two authors independently extracted the data. To assess the risk of bias, the Cochrane Collaborations risk of bias tool was used. The Review Manager ver. 5.1 (RevMan) was used for statistics. Results: We identified 5 studies. The relative benefit for participants with pain relief was 1.00 (95% confidence interval [CI], 0.96 to 1.05) and I 2 = 0%. The existence of the heterogeneity between studies was not important in this study, thus subgroup analysis was not implemented. The relative benefit for participants with rhinorrhea was 1.02 (95% CI, 0.77 to 1.35) and I 2 = 0%, which also indicates the existence of heterogeneity was not important. The relative risk of adverse events was 1.14 (95% CI, 0.93 to 1.40), I 2 = 0%. There was no apparent asymmetry in the funnel plot. Conclusion: There was no difference between NSAIDs and acetaminophen in Common Cold Symptom relief.

Hyun-keun Lee - One of the best experts on this subject based on the ideXlab platform.

  • A Comparison of the Efficacy and Safety of Non-Steroidal Anti-Inflammatory Drugs versus Acetaminophen in Symptom Relief for the Common Cold: A Meta-Analysis of Randomized Controlled Trial Studies
    Korean journal of family medicine, 2013
    Co-Authors: Il-kwon Choi, Hyun-keun Lee, In-hong Hwang, Soo Young Kim
    Abstract:

    Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are widely used for Common Cold Symptom relief. The objective of this study was to evaluate and compare the efficacy and safety of acetaminophen and NSAIDs in Common Cold Symptom relief using meta-analysis of randomized controlled trial. We searched MEDLINE (PubMed), Cochrane, EMBASE, CINAHL, KMbase, KoreaMed, National Assembly Library, and Riss4u for studies released through June 2012. Two authors independently extracted the data. To assess the risk of bias, the Cochrane Collaborations risk of bias tool was used. The Review Manager ver. 5.1 (RevMan) was used for statistics. We identified 5 studies. The relative benefit for participants with pain relief was 1.00 (95% confidence interval [CI], 0.96 to 1.05) and I(2) = 0%. The existence of the heterogeneity between studies was not important in this study, thus subgroup analysis was not implemented. The relative benefit for participants with rhinorrhea was 1.02 (95% CI, 0.77 to 1.35) and I(2) = 0%, which also indicates the existence of heterogeneity was not important. The relative risk of adverse events was 1.14 (95% CI, 0.93 to 1.40), I(2) = 0%. There was no apparent asymmetry in the funnel plot. There was no difference between NSAIDs and acetaminophen in Common Cold Symptom relief.

  • a comparison of the efficacy and safety of non steroidal anti inflammatory drugs versus acetaminophen in Symptom relief for the Common Cold a meta analysis of randomized controlled trial studies
    Korean Journal of Family Medicine, 2013
    Co-Authors: Il-kwon Choi, Hyun-keun Lee, In-hong Hwang, Soo Young Kim
    Abstract:

    Background: Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are widely used for Common Cold Symptom relief. The objective of this study was to evaluate and compare the efficacy and safety of acetaminophen and NSAIDs in Common Cold Symptom relief using meta-analysis of randomized controlled trial. Methods: We searched MEDLINE (PubMed), Cochrane, EMBASE, CINAHL, KMbase, KoreaMed, National Assembly Library, and Riss4u for studies released through June 2012. Two authors independently extracted the data. To assess the risk of bias, the Cochrane Collaborations risk of bias tool was used. The Review Manager ver. 5.1 (RevMan) was used for statistics. Results: We identified 5 studies. The relative benefit for participants with pain relief was 1.00 (95% confidence interval [CI], 0.96 to 1.05) and I 2 = 0%. The existence of the heterogeneity between studies was not important in this study, thus subgroup analysis was not implemented. The relative benefit for participants with rhinorrhea was 1.02 (95% CI, 0.77 to 1.35) and I 2 = 0%, which also indicates the existence of heterogeneity was not important. The relative risk of adverse events was 1.14 (95% CI, 0.93 to 1.40), I 2 = 0%. There was no apparent asymmetry in the funnel plot. Conclusion: There was no difference between NSAIDs and acetaminophen in Common Cold Symptom relief.

Kozo Nakanishi - One of the best experts on this subject based on the ideXlab platform.

  • Proof of the mysterious efficacy of ginseng: basic and clinical trials: clinical effects of medical ginseng, korean red ginseng: specifically, its anti-stress action for prevention of disease.
    Journal of pharmacological sciences, 2004
    Co-Authors: Hitoshi Kaneko, Kozo Nakanishi
    Abstract:

    We are exposed to many external and internal stresses in this day and age. Stress weakens the function of immune systems in living organisms and disturbs homeostasis. As a result, stress induces various psychosomatic diseases. Thus, ways of reducing stress and thus protecting humans from disease must be developed. One such method is called "the prevention of Mibyou" in Kampo, the Chinese traditional medicine. Many studies have reported the direct effects of medical ginseng on damaged target organs and recovery from disease. It also increases immune potential and may maintain homeostasis of living organisms through the autonomic-endocrine systems. It is also thought to prevent the development of disease. We studied and considered the action of medical ginseng on living organisms that were exposed to various stresses such as Cold environment and industrial work. Furthermore, we confirmed the preventive effects of medical ginseng on the Common Cold Symptom complex, including flu, by clinical observation. Here, we report our experiences.